---
title: "Weekly Recap | JACOBIO-B +4.16%, consensus target above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300842575.md"
description: "JACOBIO-B (1167.HK) gained 4.16% this week to close at HK$6.015, while the Hang Seng Index fell 2.72% over the same period. The stock outperformed the benchmark by roughly 6.88 percentage points. With only three trading days, price action opened higher and then consolidated: Monday saw a close of HK$5.990 from an open of HK$5.815, Tuesday pushed to a weekly high of HK$6.165 before settling at HK$6.060, and Thursday pulled back to a low of HK$5.650 before closing at HK$6.015."
datetime: "2026-10-03T05:09:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300842575.md)
  - [en](https://longbridge.com/en/news/300842575.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300842575.md)
generator: "portal-rs"
---

# Weekly Recap | JACOBIO-B +4.16%, consensus target above spot

## The Week

JACOBIO-B (1167.HK) gained 4.16% this week to close at HK$6.015, while the Hang Seng Index fell 2.72% over the same period. The stock outperformed the benchmark by roughly 6.88 percentage points. With only three trading days, price action opened higher and then consolidated: Monday saw a close of HK$5.990 from an open of HK$5.815, Tuesday pushed to a weekly high of HK$6.165 before settling at HK$6.060, and Thursday pulled back to a low of HK$5.650 before closing at HK$6.015. There was no major catalyst this week; trading was quiet, with average daily volume around 1.01 million shares, over 50% below the median.\\n\\n## Analyst Ratings\\n\\nTwo brokers cover the stock: one rates it buy, one rates it hold. Consensus stands at buy, with a consensus target of HK$9.799, about 62.9% above the latest close. Targets range from HK$9.255 to HK$10.343, indicating limited disagreement. Within its industry, the stock ranks 28th out of 52 biotechnology names, placing it in the lower-middle tier.\\n\\n## The Week Ahead\\n\\nAttention shifts to macro data next. Hong Kong will release its unemployment rate (previous: 3.8) and composite CPI (previous: 1.7) on Thursday, 22 October. No earnings or company-specific events are scheduled; the next catalyst to watch is any fresh clinical or commercial update from the biotech sector.\\n\\n*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*\\n

### Related Stocks

- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)

## Related News & Research

- [Jacobio doses first patient in Phase IIa China trial of JAB-8263 for rheumatoid arthritis](https://longbridge.com/en/news/293854649.md)
- [Jacobio Pharmaceuticals Group: Revenue up 1499% and net profit reached RMB600.6 million, fueled by major licensing deals](https://longbridge.com/en/news/296791061.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)
- [Google Is Turning Its AI Rivals Into Chip Customers. Nvidia Should Pay Attention](https://longbridge.com/en/news/306283808.md)
- [AI tech rout prompts US investors to rush into value stocks](https://longbridge.com/en/news/306321872.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**